Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 4528941, 7 pages
https://doi.org/10.1155/2017/4528941
Review Article

De Novo Human Cardiac Myocytes for Medical Research: Promises and Challenges

1University of Ottawa Heart Institute & Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada
2Department of Cardiology, Xi’an No. 3 Hospital, Xi’an, China
3Department of Cardiology, Xi’an Central Hospital, Xi’an, China
4Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
5Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
6Department of Cardiology, Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

Correspondence should be addressed to Wenbin Liang; ac.awattou@3nailw

Received 7 October 2016; Revised 23 January 2017; Accepted 1 February 2017; Published 20 February 2017

Academic Editor: Gary E. Lyons

Copyright © 2017 Veronique Hamel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Mozaffarian, E. J. Benjamin, A. S. Go et al., “Heart disease and stroke statistics—2016 update: a report from the American Heart Association,” Circulation, vol. 133, no. 4, pp. e38–e360, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. D. E. Bloom, E. T. Cafiero, E. Jané-Llopis et al., The Global Economic Burden of Non-Communicable Diseases, World Economic Forum, Geneva, Switzerland, 2011.
  3. Z. P. Qureshi, E. Seoane-Vazquez, R. Rodriguez-Monguio, K. B. Stevenson, and S. L. Szeinbach, “Market withdrawal of new molecular entities approved in the United States from 1980 to 2009,” Pharmacoepidemiology and Drug Safety, vol. 20, no. 7, pp. 772–777, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. S. V. Pandit, “Ionic mechanisms of atrial action potentials,” in Cardiac Electrophysiology: From Cell to Bedside, D. P. J. Zipes, Ed., pp. 309–311, Elsevier, 2015. View at Google Scholar
  5. I. Y. Chen, E. Matsa, and J. C. Wu, “Induced pluripotent stem cells: at the heart of cardiovascular precision medicine,” Nature Reviews Cardiology, vol. 13, no. 6, pp. 333–349, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Srivastava and N. DeWitt, “In vivo cellular reprogramming: the next generation,” Cell, vol. 166, no. 6, pp. 1386–1396, 2016. View at Publisher · View at Google Scholar
  7. J. A. Thomson, J. Itskovitz-Eldor, S. S. Shapiro et al., “Embryonic stem cell lines derived from human blastocysts,” Science, vol. 282, no. 5391, pp. 1145–1147, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. M. J. Evans and M. H. Kaufman, “Establishment in culture of pluripotential cells from mouse embryos,” Nature, vol. 292, no. 5819, pp. 154–156, 1981. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Kehat, D. Kenyagin-Karsenti, M. Snir et al., “Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes,” The Journal of Clinical Investigation, vol. 108, no. 3, pp. 407–414, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Xu, S. Police, N. Rao, and M. K. Carpenter, “Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells,” Circulation Research, vol. 91, no. 6, pp. 501–508, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Takahashi and S. Yamanaka, “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors,” Cell, vol. 126, no. 4, pp. 663–676, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Tanaka, S. Tohyama, M. Murata et al., “In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes,” Biochemical and Biophysical Research Communications, vol. 385, no. 4, pp. 497–502, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Zhang, G. F. Wilson, A. G. Soerens et al., “Functional cardiomyocytes derived from human induced pluripotent stem cells,” Circulation Research, vol. 104, no. 4, pp. e30–e41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Ma, L. Guo, S. J. Fiene et al., “High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 301, no. 5, pp. H2006–H2017, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. C. L. Mummery, J. Zhang, E. S. Ng, D. A. Elliott, A. G. Elefanty, and T. J. Kamp, “Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview,” Circulation Research, vol. 111, no. 3, pp. 344–358, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. V. A. Maltsev, J. Rohwedel, J. Hescheler, and A. M. Wobus, “Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types,” Mechanisms of Development, vol. 44, no. 1, pp. 41–50, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Yang, M. H. Soonpaa, E. D. Adler et al., “Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population,” Nature, vol. 453, no. 7194, pp. 524–528, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. J. Kattman, A. D. Witty, M. Gagliardi et al., “Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines,” Cell Stem Cell, vol. 8, no. 2, pp. 228–240, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Zhang, M. Klos, G. F. Wilson et al., “Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method,” Circulation Research, vol. 111, no. 9, pp. 1125–1136, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Lian, C. Hsiao, G. Wilson et al., “Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 27, pp. E1848–E1857, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. P. W. Burridge, E. Matsa, P. Shukla et al., “Chemically defined generation of human cardiomyocytes,” Nature Methods, vol. 11, no. 8, pp. 855–860, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Lian, X. Bao, M. Zilberter et al., “Chemically defined, albumin-free human cardiomyocyte generation,” Nature Methods, vol. 12, no. 7, pp. 595–596, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Ieda, J.-D. Fu, P. Delgado-Olguin et al., “Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors,” Cell, vol. 142, no. 3, pp. 375–386, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Inagawa, K. Miyamoto, H. Yamakawa et al., “Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5,” Circulation Research, vol. 111, no. 9, pp. 1147–1156, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Qian, Y. Huang, C. I. Spencer et al., “In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes,” Nature, vol. 485, no. 7400, pp. 593–598, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Wang, Z. Liu, C. Yin et al., “Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming,” Circulation Research, vol. 116, no. 2, pp. 237–244, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Zhou, L. Wang, H. R. Vaseghi et al., “Bmi1 is a key epigenetic barrier to direct cardiac reprogramming,” Cell Stem Cell, vol. 18, no. 3, pp. 382–395, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. J.-D. Fu, N. R. Stone, L. Liu et al., “Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state,” Stem Cell Reports, vol. 1, no. 3, pp. 235–247, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. T. M. Jayawardena, B. Egemnazarov, E. A. Finch et al., “MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes,” Circulation Research, vol. 110, no. 11, pp. 1465–1473, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Song, Y.-J. Nam, X. Luo et al., “Heart repair by reprogramming non-myocytes with cardiac transcription factors,” Nature, vol. 485, no. 7400, pp. 599–604, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Muraoka, H. Yamakawa, K. Miyamoto et al., “MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures,” EMBO Journal, vol. 33, no. 14, pp. 1565–1581, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. T. M. Jayawardena, E. A. Finch, L. Zhang et al., “MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function,” Circulation Research, vol. 116, no. 3, pp. 418–424, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Cao, Y. Huang, J. Zheng et al., “Conversion of human fibroblasts into functional cardiomyocytes by small molecules,” Science, vol. 352, no. 6290, pp. 1216–1220, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Li, G. Chen, and R. A. Li, “Calcium signalling of human pluripotent stem cell-derived cardiomyocytes,” Journal of Physiology, vol. 591, no. 21, pp. 5279–5290, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Yang, L. Pabon, and C. E. Murry, “Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes,” Circulation Research, vol. 114, no. 3, pp. 511–523, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Uosaki, P. Cahan, D. I. Lee et al., “Transcriptional landscape of cardiomyocyte maturation,” Cell Reports, vol. 13, no. 8, pp. 1705–1716, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Sartiani, E. Bettiol, F. Stillitano, A. Mugelli, E. Cerbai, and M. E. Jaconi, “Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach,” Stem Cells, vol. 25, no. 5, pp. 1136–1144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Kadota, I. Minami, N. Morone, J. E. Heuser, K. Agladze, and N. Nakatsuji, “Development of a reentrant arrhythmia model in human pluripotent stem cell-derived cardiac cell sheets,” European Heart Journal, vol. 34, no. 15, pp. 1147–1156, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. S. D. Lundy, W.-Z. Zhu, M. Regnier, and M. A. Laflamme, “Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells,” Stem Cells and Development, vol. 22, no. 14, pp. 1991–2002, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. S. S. Nunes, J. W. Miklas, J. Liu et al., “Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes,” Nature Methods, vol. 10, no. 8, pp. 781–787, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. Y.-C. Chan, S. Ting, Y.-K. Lee et al., “Electrical stimulation promotes maturation of cardiomyocytes derived from human embryonic stem cells,” Journal of Cardiovascular Translational Research, vol. 6, no. 6, pp. 989–999, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. M. N. Hirt, J. Boeddinghaus, A. Mitchell et al., “Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation,” Journal of Molecular and Cellular Cardiology, vol. 74, pp. 151–161, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Földes, M. Mioulane, J. S. Wright et al., “Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy?” Journal of Molecular and Cellular Cardiology, vol. 50, no. 2, pp. 367–376, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Mihic, J. Li, Y. Miyagi et al., “The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cell-derived cardiomyocytes,” Biomaterials, vol. 35, no. 9, pp. 2798–2808, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. I. Klein and K. Ojamaa, “Thyroid hormone and the cardiovascular system,” New England Journal of Medicine, vol. 344, no. 7, pp. 501–509, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. Y.-K. Lee, K.-M. Ng, Y.-C. Chan et al., “Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway,” Molecular Endocrinology, vol. 24, no. 9, pp. 1728–1736, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. X. Yang, M. Rodriguez, L. Pabon et al., “Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells,” Journal of Molecular and Cellular Cardiology, vol. 72, pp. 296–304, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. J.-D. Fu, S. N. Rushing, D. K. Lieu et al., “Distinct roles of microRNA-1 and -499 in ventricular specification and functional maturation of human embryonic stem Cell-Derived cardiomyocytes,” PLoS ONE, vol. 6, no. 11, Article ID e27417, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Schram, M. Pourrier, P. Melnyk, and S. Nattel, “Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function,” Circulation Research, vol. 90, no. 9, pp. 939–950, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. J. J. H. Chong, X. Yang, C. W. Don et al., “Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts,” Nature, vol. 510, no. 7504, pp. 273–277, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. Q. Zhang, J. Jiang, P. Han et al., “Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals,” Cell Research, vol. 21, no. 4, pp. 579–587, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. H. D. Devalla, V. Schwach, J. W. Ford et al., “Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology,” EMBO Molecular Medicine, vol. 7, no. 4, pp. 394–410, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. Z. Weng, C.-W. Kong, L. Ren et al., “A simple, cost-effective but highly efficient system for deriving ventricular cardiomyocytes from human pluripotent stem cells,” Stem Cells and Development, vol. 23, no. 14, pp. 1704–1716, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Kapoor, W. Liang, E. Marbán, and H. C. Cho, “Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18,” Nature Biotechnology, vol. 31, no. 1, pp. 54–62, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. Y.-F. Hu, J. F. Dawkins, H. C. Cho, E. Marbán, and E. Cingolani, “Biological pacemaker created by minimally invasive somatic reprogramming in pigs with complete heart block,” Science Translational Medicine, vol. 6, no. 245, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. J. J. Jung, B. Husse, C. Rimmbach et al., “Programming and isolation of highly pure physiologically and pharmacologically functional sinus-nodal bodies from pluripotent stem cells,” Stem Cell Reports, vol. 2, no. 5, pp. 592–605, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. V. Ionta, W. Liang, E. H. Kim et al., “SHOX2 overexpression favors differentiation of embryonic stem cells into cardiac pacemaker cells, improving biological pacing ability,” Stem Cell Reports, vol. 4, no. 1, pp. 129–142, 2015. View at Publisher · View at Google Scholar · View at Scopus